Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
Ra Medical Systems, Inc. (RMED)
|
Add to portfolio |
|
|
|
| Price: |
$1.62
| | Metrics |
| OS: |
5.37
|
M
| |
|
|
| Market cap: |
$8.7
|
M
| |
|
|
|
Net cash:
|
$4.11
|
M
| |
$0.77
|
per share
|
|
EV:
|
$4.58
|
M
| | | |
| | | | | |
| TTM Valuation | | | |
|
EBITDA
|
|
| |
|
|
|
EBIT
|
|
| |
|
|
| EPS |
| |
|
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 |
| Revenues | 0.0 | 4.4 | 7.2 | 6.3 | 5.9 | 6.0 |
| Revenue growth | -99.5% | -38.8% | 15.1% | 6.6% | -1.8% | |
| Cost of goods sold | 1.6 | 5.5 | 8.9 | 4.2 | 4.2 | 3.1 |
| Gross profit | -1.5 | -1.1 | -1.7 | 2.1 | 1.7 | 2.8 |
| Gross margin | -6990.9% | -24.4% | -22.9% | 32.8% | 29.0% | 47.5% |
| Selling, general and administrative | 15.5 | 26.0 | 51.5 | 30.4 | 14.9 | 5.3 |
| Research and development | 12.3 | 9.0 | 4.5 | 2.8 | 4.5 | 1.7 |
| EBIT | -29.3 | -36.1 | -57.7 | -31.2 | -17.8 | -4.2 |
| EBIT margin | -133027.3% | -818.6% | -801.9% | -498.0% | -302.6% | -70.2% |
| Pre-tax income | -27.3 | -36.0 | -56.9 | -30.8 | -17.8 | -4.2 |
| Income taxes | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Earnings from continuing ops | -27.3 | -36.0 | -57.0 | -30.8 | -17.8 | -4.2 |
| Earnings from discontinued ops | 2.2 | | | | | |
| Net income | -25.1 | -36.0 | -57.0 | -30.8 | -17.8 | -4.2 |
| Net margin | -113954.5% | -818.3% | -791.2% | -492.8% | -302.6% | -70.3% |
| |
| Diluted EPS | ($5.39) | ($21.22) | ($108.28) | ($3.34) | ($2.35) | ($0.60) |
| Shares outstanding (diluted) | 5.1 | 1.7 | 0.5 | 9.2 | 7.5 | 7.0 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|